Home Finance Teva climbs premarket as FDA approves once-monthly schizophrenia treatment
Finance

Teva climbs premarket as FDA approves once-monthly schizophrenia treatment

Share
Teva climbs premarket as FDA approves once-monthly schizophrenia treatment
Share


Teva climbs premarket as FDA approves once-monthly schizophrenia treatment

Source link

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *